ordinary shares and Baht 27.59 million from the exercise of warrants (FVC-W1). As result, the shareholders' equity as increased. While the performance in 2017, has grown significantly from the previous year

Discussion and Analysis (MD&A) for year 2017 3 Executive Summary In overall 2017 performance, the Company had significant improvements in various areas such as production increase to 875,874 tons, sale volume

on Q1/2018 Management’s Discussion and Analysis (MD&A) for year 2017 (Revised) 3 Executive Summary In overall 2017 performance, the Company had significant improvements in various areas such as

statements for the year ended February 29, 2020 which were audited by Deloitte Touche Tohmatsu Jaiyos Audit Company Limited. The operating performance is summarized as follows. Overview According to the Bank

the guidance. FY19 performance & FY20 outlook FY19 performance tracked in-line with all guidance. Service revenue of Bt140,454mn grew 5.3% YoY vs guidance of mid- single digit growth. EBITDA reported

performance. 7. Company’s direction in 2019 Overall significant events are as follows. 7. 1 KT Medical Services Co., Ltd. operates a hemodialysis center to patients with chronic kidney disease. Present, patient

and distribution of biodiesel from CPO industry, which is the inherent risk that significantly impact on the Company's performance that is the risk of fluctuation in CPO price; mostly caused by the

several financial institutions. A summary of the key operational matters and events for the 1st Quarter 2019 Overall financial performance of GFPT Group in 1Q2019 improved from the same period last year

569.35 6.85 357.50 4.64 211.85 59.26 Overall financial performance of GFPT Group in 2Q2019 improved from the same period last year thanks to higher revenue from sales, higher share of profit from

significantly impact on the Company's performance that is the risk of fluctuation in CPO price; mostly caused by the intervention of the government to determine the CPO pricing policy, economic change, climate